HOME › DRUGS › LAROPIPRANT;NICOTINIC ACID
ACTIVE SUBSTANCE / INN

LAROPIPRANT;NICOTINIC ACID

Brand name(s): Pelzont, Tredaptive, Trevaclyn
EMA LISTED
WITHDRAWN
Dyslipidemias
ACTIVE SUBSTANCE
Laropiprant;Nicotinic Acid
REGULATORS
EMA
SPONSORS / MAH
Merck Sharp Dohme Ltd, Merck Sharp Dohme Ltd.
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TrevaclynMerck Sharp Dohme LtdWithdrawn03/07/2008Dyslipidemias
PelzontMerck Sharp Dohme LtdWithdrawn03/07/2008Dyslipidemias
TredaptiveMerck Sharp Dohme Ltd.Withdrawn03/07/2008Dyslipidemias

FULL INTELLIGENCE ON LAROPIPRANT;NICOTINIC ACID

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →